Autor: "Du F" - OpacWWW - Prolib Integro

Skocz do pozycji: 1.

Tytuł:: Development of multiplex digital PCR assays for the detection of PIK3CA mutations in the plasma of metastatic breast cancer patients.
Autorzy:: Corné J; Department of Biology, Centre Eugène Marquis, Unicancer, Rennes, France. .
Le Du F; Department of Medical Oncology, Centre Eugène Marquis, Unicancer, Rennes, France.
Quillien V; Department of Biology, Centre Eugène Marquis, Unicancer, Rennes, France.; INSERM U1242, University of Rennes, Rennes, France.
Godey F; Department of Biology, Centre Eugène Marquis, Unicancer, Rennes, France.; INSERM U1242, University of Rennes, Rennes, France.
Robert L; Department of Medical Oncology, Centre Eugène Marquis, Unicancer, Rennes, France.
Bourien H; Department of Medical Oncology, Centre Eugène Marquis, Unicancer, Rennes, France.
Brunot A; Department of Medical Oncology, Centre Eugène Marquis, Unicancer, Rennes, France.
Crouzet L; Department of Medical Oncology, Centre Eugène Marquis, Unicancer, Rennes, France.
Perrin C; Department of Medical Oncology, Centre Eugène Marquis, Unicancer, Rennes, France.
Lefeuvre-Plesse C; Department of Medical Oncology, Centre Eugène Marquis, Unicancer, Rennes, France.
Diéras V; Department of Medical Oncology, Centre Eugène Marquis, Unicancer, Rennes, France.
De la Motte Rouge T; Department of Medical Oncology, Centre Eugène Marquis, Unicancer, Rennes, France.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2021 Aug 27; Vol. 11 (1), pp. 17316. Date of Electronic Publication: 2021 Aug 27.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Biomarkers, Tumor/*genetics
Breast Neoplasms/*genetics
Cell-Free Nucleic Acids/*analysis
Class I Phosphatidylinositol 3-Kinases/*genetics
Adolescent ; Base Sequence ; Breast Neoplasms/diagnosis ; Child ; Child, Preschool ; Class I Phosphatidylinositol 3-Kinases/metabolism ; Female ; Humans ; Infant ; Infant, Newborn ; Mutation ; Polymerase Chain Reaction ; Reproducibility of Results ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy.
Autorzy:: Le Du F; Department of Breast Medical Oncology, Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.; Department of Medical Oncology, Eugène Marquis Cancer Center, Rennes, France.
Fujii T; Department of Breast Medical Oncology, Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Kida K; Department of Breast Medical Oncology, Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Davis DW; ApoCell, Inc., Houston, Texas, United States of America.
Park M; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Liu DD; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Wu W; ApoCell, Inc., Houston, Texas, United States of America.
Chavez-MacGregor M; Department of Breast Medical Oncology, Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Barcenas CH; Department of Breast Medical Oncology, Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Valero V; Department of Breast Medical Oncology, Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Tripathy D; Department of Breast Medical Oncology, Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Reuben JM; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.
Ueno NT; Department of Breast Medical Oncology, Section of Translational Breast Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2020 Mar 26; Vol. 15 (3), pp. e0229903. Date of Electronic Publication: 2020 Mar 26 (Print Publication: 2020).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Breast Neoplasms/*blood
Cadherins/*blood
Epithelial Cell Adhesion Molecule/*blood
Neoplastic Cells, Circulating/*metabolism
Adult ; Aged ; Antigens, Neoplasm/blood ; Biomarkers, Tumor/blood ; Breast Neoplasms/classification ; Breast Neoplasms/drug therapy ; Breast Neoplasms/pathology ; Cell Count ; Cell Line, Tumor ; Epithelial-Mesenchymal Transition/genetics ; Female ; Humans ; Middle Aged ; Neoadjuvant Therapy ; Neoplastic Stem Cells/metabolism ; Neoplastic Stem Cells/pathology ; Proto-Oncogene Proteins c-bcl-2/blood ; Vimentin/blood

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: The Demographic Features, Clinicopathological Characteristics and Cancer-specific Outcomes for Patients with Microinvasive Breast Cancer: A SEER Database Analysis.
Autorzy:: Wang W; Department of Medical Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Zhu W; Department of Medical Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Du F; Department of Medical Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Luo Y; Department of Medical Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Xu B; Department of Medical Oncology, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2017 Feb 06; Vol. 7, pp. 42045. Date of Electronic Publication: 2017 Feb 06.
Typ publikacji:: Journal Article; Observational Study
MeSH Terms:: Breast Neoplasms/*epidemiology
Breast Neoplasms/*pathology
Carcinoma, Intraductal, Noninfiltrating/*epidemiology
Carcinoma, Intraductal, Noninfiltrating/*pathology
Adult ; Black or African American ; Breast Neoplasms/mortality ; Carcinoma, Intraductal, Noninfiltrating/mortality ; Female ; Humans ; Lymphatic Metastasis ; Middle Aged ; Prognosis ; Receptor, ErbB-2/metabolism ; Receptors, Estrogen/metabolism ; Receptors, Progesterone/metabolism ; Survival Analysis

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis.
Autorzy:: Lefebvre C; INSERM Unit U981, Gustave Roussy, Villejuif, France.
Bachelot T; Department of Medical Oncology, Centre Léon Bérard, Inserm U1052, Lyon, France.
Filleron T; Biostatistics Department, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France.
Pedrero M; INSERM Unit U981, Gustave Roussy, Villejuif, France.
Campone M; Department of Medical Oncology, Institut de Cancérologie de l'Ouest, Nantes, France.
Soria JC; INSERM Unit U981, Gustave Roussy, Villejuif, France.; Department of Medical Oncology, Gustave Roussy, Villejuif, France.; Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre, France.; Drug Development Department (DITEP), Gustave Roussy, Villejuif, France.
Massard C; Drug Development Department (DITEP), Gustave Roussy, Villejuif, France.
Lévy C; Department of Medical Oncology, Centre François Baclesse, Caen, France.
Arnedos M; Department of Medical Oncology, Gustave Roussy, Villejuif, France.
Lacroix-Triki M; INSERM Unit U981, Gustave Roussy, Villejuif, France.
Garrabey J; R&D UNICANCER, Paris, France.
Boursin Y; Bioinformatics core facility, Gustave Roussy, Villejuif, France.
Deloger M; Bioinformatics core facility, Gustave Roussy, Villejuif, France.
Fu Y; INSERM Unit U981, Gustave Roussy, Villejuif, France.
Commo F; INSERM Unit U981, Gustave Roussy, Villejuif, France.
Scott V; INSERM Unit U981, Gustave Roussy, Villejuif, France.
Lacroix L; INSERM Unit U981, Gustave Roussy, Villejuif, France.; Department of Medical Biology and Pathology, Translational research laboratory and biobank, Gustave Roussy, Villejuif, France.
Dieci MV; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padua, Italy.; Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
Kamal M; Department of Medical Oncology, Institut Curie, Paris & Saint-Cloud, France.
Diéras V; Department of Medical Oncology, Institut Curie, Paris & Saint-Cloud, France.
Gonçalves A; Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France.
Ferrerro JM; Department of Clinical Research, Centre Antoine Lacassagne, Nice, France.
Romieu G; Department of Medical Oncology, Institut du Cancer de Montpellier, Montpellier, France.
Vanlemmens L; Department of Medical Oncology, Centre Oscar Lambret, Lille, France.
Mouret Reynier MA; Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France.
Théry JC; Department of Medical Oncology, Centre Henri Becquerel, Rouen, France.
Le Du F; Department of Medical Oncology, Centre Eugène Marquis, Rennes, France.
Guiu S; Department of Medical Oncology, Centre Georges-François Leclerc, Dijon, France.
Dalenc F; Department of Medical Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France.
Clapisson G; UNICANCER Biobanking Center, Centre Léon Bérard, Lyon, France.
Bonnefoi H; Department of Medical Oncology, Institut Bergonié, Université de Bordeaux, INSERM U916, Bordeaux, France.
Jimenez M; R&D UNICANCER, Paris, France.
Le Tourneau C; Department of Medical Oncology, Institut Curie, Paris & Saint-Cloud, France.; EA7285, Versailles-Saint-Quentin-en-Yvelines University, Montigny-le-Bretonneux, France.
André F; INSERM Unit U981, Gustave Roussy, Villejuif, France.; Department of Medical Oncology, Gustave Roussy, Villejuif, France.; Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre, France.; Pokaż więcej
Źródło:: PLoS medicine [PLoS Med] 2016 Dec 27; Vol. 13 (12), pp. e1002201. Date of Electronic Publication: 2016 Dec 27 (Print Publication: 2016).
Typ publikacji:: Journal Article
MeSH Terms:: Exome*
Mutation*
Breast Neoplasms/*genetics
Breast Neoplasms/*pathology
Female ; Humans ; Neoplasm Metastasis ; Retrospective Studies ; Sequence Analysis, DNA

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: A miRNA-based signature predicts development of disease recurrence in HER2 positive breast cancer after adjuvant trastuzumab-based treatment.
Autorzy:: Du F; Department of Medical Oncology, Cancer Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, National Cancer Center, Beijing, China.; The VIPII Gastrointestinal Cancer Division of Medical Department, Peking University Cancer Hospital and Institute, 52 Fucheng Road, Haidian District, Beijing, China.
Yuan P; Department of Medical Oncology, Cancer Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, National Cancer Center, Beijing, China.
Zhao ZT; State Key Laboratory of Molecular Oncology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Yang Z; Department of Cancer Epidemiology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Wang T; Tumor Marker Research Center, Cancer Institute and Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Zhao JD; Department of Medical Oncology, Cancer Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, National Cancer Center, Beijing, China.
Luo Y; Department of Medical Oncology, Cancer Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, National Cancer Center, Beijing, China.
Ma F; Department of Medical Oncology, Cancer Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, National Cancer Center, Beijing, China.
Wang JY; Department of Medical Oncology, Cancer Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, National Cancer Center, Beijing, China.
Fan Y; Department of Medical Oncology, Cancer Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, National Cancer Center, Beijing, China.
Cai RG; Department of Medical Oncology, Cancer Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, National Cancer Center, Beijing, China.
Zhang P; Department of Medical Oncology, Cancer Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, National Cancer Center, Beijing, China.
Li Q; Department of Medical Oncology, Cancer Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, National Cancer Center, Beijing, China.
Song YM; State Key Laboratory of Molecular Oncology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xu BH; Department of Medical Oncology, Cancer Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, National Cancer Center, Beijing, China.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2016 Sep 21; Vol. 6, pp. 33825. Date of Electronic Publication: 2016 Sep 21.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Gene Expression Profiling*
Breast Neoplasms/*drug therapy
Breast Neoplasms/*genetics
MicroRNAs/*genetics
Neoplasm Recurrence, Local/*pathology
Receptor, ErbB-2/*metabolism
Trastuzumab/*therapeutic use
Breast Neoplasms/pathology ; Chemotherapy, Adjuvant ; Female ; Gene Expression Regulation, Neoplastic/drug effects ; Humans ; Kaplan-Meier Estimate ; MicroRNAs/metabolism ; Middle Aged ; Multivariate Analysis ; Prognosis ; Proportional Hazards Models ; ROC Curve ; Reproducibility of Results ; Time Factors ; Trastuzumab/pharmacology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Whole-genome analysis informs breast cancer response to aromatase inhibition.
Autorzy:: Ellis MJ; Department of Internal Medicine, Division of Oncology, Washington University, St Louis, Missouri 63110, USA.
Ding L
Shen D
Luo J
Suman VJ
Wallis JW
Van Tine BA
Hoog J
Goiffon RJ
Goldstein TC
Ng S
Lin L
Crowder R
Snider J
Ballman K
Weber J
Chen K
Koboldt DC
Kandoth C
Schierding WS
McMichael JF
Miller CA
Lu C
Harris CC
McLellan MD
Wendl MC
DeSchryver K
Allred DC
Esserman L
Unzeitig G
Margenthaler J
Babiera GV
Marcom PK
Guenther JM
Leitch M
Hunt K
Olson J
Tao Y
Maher CA
Fulton LL
Fulton RS
Harrison M
Oberkfell B
Du F
Demeter R
Vickery TL
Elhammali A
Piwnica-Worms H
McDonald S
Watson M
Dooling DJ
Ota D
Chang LW
Bose R
Ley TJ
Piwnica-Worms D
Stuart JM
Wilson RK
Mardis ER; Pokaż więcej
Źródło:: Nature [Nature] 2012 Jun 10; Vol. 486 (7403), pp. 353-60. Date of Electronic Publication: 2012 Jun 10.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Aromatase/*metabolism
Aromatase Inhibitors/*therapeutic use
Breast Neoplasms/*drug therapy
Breast Neoplasms/*genetics
Genome, Human/*genetics
Anastrozole ; Androstadienes/pharmacology ; Androstadienes/therapeutic use ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/therapeutic use ; Breast Neoplasms/metabolism ; Breast Neoplasms/pathology ; DNA Repair ; Exome/genetics ; Exons/genetics ; Female ; Genetic Variation/genetics ; Humans ; Letrozole ; MAP Kinase Kinase 4/genetics ; MAP Kinase Kinase Kinase 1/genetics ; Mutation/genetics ; Nitriles/pharmacology ; Nitriles/therapeutic use ; Receptors, Estrogen/metabolism ; Treatment Outcome ; Triazoles/pharmacology ; Triazoles/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Genome remodelling in a basal-like breast cancer metastasis and xenograft.
Autorzy:: Ding L; The Genome Center at Washington University, St Louis, Missouri 63108, USA.
Ellis MJ
Li S
Larson DE
Chen K
Wallis JW
Harris CC
McLellan MD
Fulton RS
Fulton LL
Abbott RM
Hoog J
Dooling DJ
Koboldt DC
Schmidt H
Kalicki J
Zhang Q
Chen L
Lin L
Wendl MC
McMichael JF
Magrini VJ
Cook L
McGrath SD
Vickery TL
Appelbaum E
Deschryver K
Davies S
Guintoli T
Lin L
Crowder R
Tao Y
Snider JE
Smith SM
Dukes AF
Sanderson GE
Pohl CS
Delehaunty KD
Fronick CC
Pape KA
Reed JS
Robinson JS
Hodges JS
Schierding W
Dees ND
Shen D
Locke DP
Wiechert ME
Eldred JM
Peck JB
Oberkfell BJ
Lolofie JT
Du F
Hawkins AE
O'Laughlin MD
Bernard KE
Cunningham M
Elliott G
Mason MD
Thompson DM Jr
Ivanovich JL
Goodfellow PJ
Perou CM
Weinstock GM
Aft R
Watson M
Ley TJ
Wilson RK
Mardis ER; Pokaż więcej
Źródło:: Nature [Nature] 2010 Apr 15; Vol. 464 (7291), pp. 999-1005.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Neoplasm Transplantation*
Brain Neoplasms/*genetics
Brain Neoplasms/*secondary
Breast Neoplasms/*genetics
Genome, Human/*genetics
Mutation/*genetics
Adult ; Breast Neoplasms/pathology ; DNA Copy Number Variations/genetics ; DNA Mutational Analysis ; Disease Progression ; Female ; Gene Frequency/genetics ; Genomics ; Humans ; Translocation, Genetic/genetics ; Transplantation, Heterologous ; alpha Catenin/genetics

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 8.

Informacja:: Dostęp do tej pozycji wymaga zalogowania się.

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 9.

Informacja:: Dostęp do tej pozycji wymaga zalogowania się.

Czasopismo naukowe

na półce

Szczegóły

Informacja

Wyszukujesz frazę ""Du F"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język